FDA Logo links to FDA home page Skip Navigation
U.S. Food and Drug Administration
HHS Logo links to Department of Health and Human Services website
horizonal rule
Dockets Management

Up

2005P-0046: Ranbaxy's Requestes that FDA Correct Its Erroneous Removal of these Patent Listings by Reinserting the Information in the Orange Book and Maintain the Listing Until Ranbaxy's Term of Exclusivity has Elapsed

Document # Received Date Filed Date Submitter Code Submitter FR Date FR Page Comment Date Files Remarks
 
CP1 02/01/2005 02/01/2005 Drug Industry Ranbaxy Laboratories Limited       pdf  
Signature: Kate C. Beardsley,Carmen M. Shepar
ACK1 02/03/2005 02/03/2005 Federal Government HFA-305 to Buc & Beardsley       pdf  
  Signature: Lyle D. Jaffe
C1 06/09/2005 06/09/2005 Private Industry Teva Pharmaceuticals USA       pdf
Exhibit A, B
 
Signature: Deborah Jaskot
RC1 07/01/2005 07/01/2005 Drug Industry Ranbaxy Laboratories, INc. (Ranbaxy)       pdf  
Signature: Kate C. Beardsley and Carmen M. Sh
RC2 07/12/2005 07/11/2005 Drug Industry Ivax Pharmaceuticals, Inc.       pdf  
Signature: Monte R. Browder
LET1 10/24/2005 10/21/2005 Drug Industry Teva Pharmaceuticals USA       pdf  
Signature: Deborah A. Jaskot, M.S., RAC
PDN1 10/26/2005 10/26/2005 Federal Government HFD-001 to Ranbaxy Laboratories Limited       pdf  
  Signature: Steven K. Galson, M.D., MPH
LET2 06/26/2006 06/26/2006 Private Industry FDA/CDER to Buc and Beardsley       pdf  
Signature: Steven K. Galson, M.D., M.P.H.

Top | Up

Page last updated July 27, 2006 kkhorizonal rule
Dockets Home Page | Dockets Contacts and Location | Operating Status | Item Code Definitions | Federal Register
FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA

FDA/Dockets Management